Connect with us

Health

Cardioprotective therapies fail to prevent LVEF decline in early breast cancer treatment – Healio

Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor…

Published

on

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor long-term decline in left ventricular ejection fraction, a speaker reported.
According to data presented at the virtual American College of Cardiology Scientific Session, concomitant…

Click here to view the original article.

You might also like ...

Article feature image
Does a plant-based diet really help beat Covid-19? – Deccan Herald
Article feature image
EU adds another rare blood condition as side effect of AstraZeneca shot – ZAWYA
Black and Latino communities are left behind in Covid-19 vaccination efforts – The Guardian